Drug Price Transparency – A False Panacea

Drug Price Transparency – A False Panacea

There has been a recent bubble of political support for increased transparency into the pricing of pharmaceuticals.  From Senator McCain’s...

Drug Pricing Under the Trump Administration

Drug Pricing Under the Trump Administration

Recently, President Donald Trump met with executives from the Pharmaceutical Research and Manufacturers of America (PhRMA) to discuss issues in...

21st Century Cures Legislation – Could it reduce drug prices?

21st Century Cures Legislation – Could it reduce drug prices?

Shifting Supply The 21st Century Cures Act aims to facilitate drug and device approvals and simplify clinical trial requirements.[1] These...

Return of the CEO

Return of the CEO

In the sixth episode of the Drug Price Wars, we get to revisit the CEO of Turing Pharmaceuticals who has...

Is Pfizer’s CEO being serious?!?

Is Pfizer’s CEO being serious?!?

Pfizer CEO Ian Read’s recent interview with Forbes may have produced one of the craziest lines I’ve ever heard: “I...

Preventastatin vs. Dontdietodaecillin: A pharmacoeconomic hypothetical.

Preventastatin vs. Dontdietodaecillin: A pharmacoeconomic hypothetical.

I made the decision to go back to academia for topics like this one: How are drug prices determined? This...

All original content on these pages is fingerprinted and certified by Digiprove